Bionanotechnology: Revolution in Food, Bio-medical, Health
Bio-nanotechnology operates at the scale of atoms and molecules. To fully grasp this scale, one may consider that the ratio of a nanometer to the diameter of a soccer ball is roughly equivalent to the ratio of a soccer ball to the planet earth. The marriage of nanotechnology and biotechnology is a natural one, as we believe that many biological processes take place at the nano scale.
We believe that nanotechnology and its cousin bio-nanotechnology represent, at this point, an enabling technology, not a product onto itself. Yet we believe that the applications of bio-nano technology to health care will be seen in several areas, including
• Drug Delivery
• Gene sequencing and analysis
Bio-nanotechnology takes most of its fundamentals from nanotechnology. Most of the devices designed for nano bio technological use are directly based on other existing nanotechnologies. Bio-nanotechnology is often used to describe the overlapping multidisciplinary activities associated with bio-sensors, particularly where photonics, chemistry, biology, biophysics, nano-medicine, and engineering converge. Measurement in biology using waveguide techniques, such as dual polarization interferometry, are another example.
The impact of Bio-nanotechnology, achieved through structural and mechanistic analyses of biological processes at nano-scale, is their translation into synthetic and technological applications through nanotechnology.
In other words, Bio-nanotechnology is essentially miniaturized biotechnology, whereas nano-biotechnology is a specific application of nanotechnology. For example, DNA nanotechnology or cellular engineering would be classified as Bio nanotechnology because they involve working with bio-molecules on the nano scale. Conversely, many new medical technologies involving nano-particles as delivery systems or as sensors would be examples of Bio nanotechnology since they involve using nanotechnology to advance the goals of biology.
Nanoshel Consulting Services in United States specially for Bio-nanotechnology companies and Individual researchers
Industry: Technology Licensing/collaboration, Biopharma-academic collaborations for the Development of new bio-therapeutic drugs with safety and efficacy. Patients: Finding cutting edge scientific solution to their current life threatening illnesses
Endocrine Technology, LLC has defined ETBOND Strategic Plan of Drug Development in accordance to Section 505(b)/ 351(a). As per FDA white paper, 2004 there is “Innovation…Stagnation” leading to escalation of drug development cost to $ 1. 7 B. The ETBOND Strategic Plan of Drug Development is innovatively defined.